郑州微飒生物科技有限责任公司 咨询热线:0371-88821766
行业动态

行业动态

追踪行业前沿,洞察产业趋势

药效评价Transient receptor potential ankyrin 1 antagonists block the noxious effects of toxic industrial isocyanates and tear gases.

期刊:FASEB journal : official publication of the Federation of American Societies for Experimental Biology发表年份:2009作者:Bret F Bessac; Michael Sivula; Christian A von Hehn; Ana I Caceres; Jasmine Escalera; Sven-Eric Jordt

药效评价Metabolism and renal elimination of gaboxadol in humans: role of UDP-glucuronosyltransferases and transporters.

期刊:Pharmaceutical research发表年份:2009作者:Xiao-Yan Chu; Yuexia Liang; Xiaoxin Cai; Karla Cuevas-Licea; Ronda K Rippley; Kelem Kassahun; Magang Shou; Matthew P Braun; George A Doss; M Reza Anari; Raymond Evers

药效评价Novel non-peptide nociceptin/orphanin FQ receptor agonist, 1-[1-(1-Methylcyclooctyl)-4-piperidinyl]-2-[(3R)-3-piperidinyl]-1H-benzimidazole: design, synthesis, and structure-activity relationship of oral receptor occupancy in the brain for orally pot

期刊:Journal of medicinal chemistry发表年份:2009作者:Shigeo Hayashi; Akiko Hirao; Aki Imai; Hiroshi Nakamura; Yoshinori Murata; Katsuyo Ohashi; Eriko Nakata

药效评价The in vitro receptor profile of rotigotine: a new agent for the treatment of Parkinson's disease.

期刊:Naunyn-Schmiedeberg's archives of pharmacology发表年份:2009作者:Dieter Scheller; Christoph Ullmer; Reinhard Berkels; Mirella Gwarek; Hermann Lübbert